Venous thromboembolism associated with estrogen-containing contraceptives versus any hormonal risk factor: a comparison of recurrence rates
- PMID: 36695380
- DOI: 10.1016/j.jtha.2022.10.009
Venous thromboembolism associated with estrogen-containing contraceptives versus any hormonal risk factor: a comparison of recurrence rates
Similar articles
-
Venous thromboembolism in women taking hormonal contraceptives.Expert Rev Cardiovasc Ther. 2010 Feb;8(2):211-5. doi: 10.1586/erc.09.175. Expert Rev Cardiovasc Ther. 2010. PMID: 20136607 Review.
-
Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: Systematic review and meta-analysis.J Thromb Haemost. 2022 May;20(5):1158-1165. doi: 10.1111/jth.15661. Epub 2022 Feb 13. J Thromb Haemost. 2022. PMID: 35108438 Free PMC article.
-
Systemic hormonal contraception and risk of venous thromboembolism.Acta Obstet Gynecol Scand. 2022 Aug;101(8):846-855. doi: 10.1111/aogs.14384. Epub 2022 May 27. Acta Obstet Gynecol Scand. 2022. PMID: 35633036 Free PMC article.
-
[Peroral hormonal contraception and risk of venous thromboembolism].Vnitr Lek. 2010 May;56(5):370-5. Vnitr Lek. 2010. PMID: 20578585 Czech.
-
The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.Am J Obstet Gynecol. 2011 Oct;205(4 Suppl):S9-13. doi: 10.1016/j.ajog.2011.06.057. Am J Obstet Gynecol. 2011. PMID: 21961825 Review.
Cited by
-
Behind the Headache: A Case of Cerebral Venous Thrombosis Associated With Hormonal Contraceptive Use.Cureus. 2025 Jul 9;17(7):e87580. doi: 10.7759/cureus.87580. eCollection 2025 Jul. Cureus. 2025. PMID: 40786304 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources